FDAnews Drug Daily Bulletin

VIROPRO INC. SIGNS ITS FIRST MAJOR AGREEMENT WITH POTENTIAL REVENUES OF U.S. $ 27 MILLION

June 16, 2006
A A

Today, Jean-Marie Dupuy, President & Chief Executive Officer of Viropro Inc., — "Viropro" or "the company" — is proud to announce the signing of a Memorandum of Understanding (MOU) with BioChallenge, a privately-held pharmaceutical company operating in Tunis. This binding MOU aims at working jointly at the development and the production of several therapeutic proteins. This first MOU is in accordance with our model built on recurring sales revenues and short and long term profitability.
Business Wire